生物活性 | |||
---|---|---|---|
描述 | Vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR and FLK1) is a receptor tyrosine kinase that regulates angiogenesis, vascular development, and embryonic hematopoiesis in response to VEGF isoforms A, C, and D. SU-5408, known as VEGFR2 Kinase Inhibitor I, is a potent, selective and cell-permeable inhibitor of mouse VEGFR2 kinase with IC50 value of 70 nM. SU5408 shows little or no effect against receptors for platelet-derived growth factor, epidermal growth factor, or insulin-like growth factor (IC50>100 µM) [2]. 3-Substituted indolin-2-ones designed and synthesized as a novel class of tyrosine kinase inhibitors which show selectivity toward different receptor tyrosine kinases(RTKs). These compounds evaluated for their relative inhibitory properties against a panel of RTKs in intact cells. SU5408 is the most potent and selective VEGFR2 inhibitor among the compounds[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.22mL 0.64mL 0.32mL |
16.11mL 3.22mL 1.61mL |
32.22mL 6.44mL 3.22mL |
参考文献 |
---|